The story of Viagra, formerly marketed by copyright, presents a complex case study for backers considering the pharmaceutical landscape . Despite its initial success and impact of vast in earnings , the intellectual property expiration has opened the door for competing medications, greatly reducing profit prospects . This change raises questions ab